Take a sneak peek at the new NIST.gov and let us know what you think!
(Please note: some content may not be complete on the beta site.).
Chronic kidney disease (CKD) is a growing problem in the U.S., and current estimates suggest that more than 20 million Americans are affected by this disease. If left untreated, kidney disease can eventually lead to kidney failure. At this point, dialysis or kidney transplant are the only options available to sustain life. Early detection of CKD is essential for minimizing the danger of kidney failure. Measurement of serum creatinine levels is the most widespread method for detection of problems in kidney function. In order to improve the accuracy of creatinine measurements, the National Kidney Disease Education Program recommended that a reference material be developed for creatinine in serum. NIST has responded to this need by developing SRM 967a Creatinine in Frozen Human Serum.
Kidney function can be evaluated by determining the glomerular filtration rate (GFR), which provides an estimate of how well the kidneys are removing waste and excess fluid from the blood. The GFR is not measured directly. Instead, a measurement of serum creatinine is performed, and this value is entered into an equation that estimates GFR. Hence, accurate determination of serum creatinine is essential for meaningful estimation of GFR and assessment of kidney function. The National Kidney Disease Education Program (NKDEP) has initiated a creatinine standardization program that is intended to help in-vitro diagnostic (IVD) manufacturers and clinical laboratories address inter-laboratory variations in creatinine measurements. NKDEP has encouraged IVD manufacturers to purchase SRM 967 as part of this standardization program. As a result, SRM 967 was widely adopted by the clinical diagnostics community. SRM 967 was introduced in early 2007, and was superseded by SRM 967a in 2009.
Additional Technical Details:
SRM 967a consists of frozen human serum with two different levels of creatinine. Level 1 (0.85 mg/dL) is within the normal range of serum creatinine levels, while Level 2 (3.88 mg/dL) is intended to correspond to levels found in chronic kidney disease. The original reference measurement procedure (formerly known as a definitive method) used at NIST for creatinine was based upon isotope dilution gas chromatography-mass spectrometry (GC-MS). This method required multi-step sample preparation as well as derivatization of the analyte prior to quantification. More recently, isotope dilution liquid chromatography-mass spectrometry (LC-MS) has been investigated as an alternative approach to creatinine measurment. Analyte derivatization was not required, and protein precipitation was sufficient to release the analyte of interest. Both GC-MS and LC-MS methods were used to certify SRM 967 Creatinine in Human Serum, and the two techniques provided comparable results. The new LC-MS method is now listed as a higher-order method by the Joint Committee for Traceability in Laboratory Medicine (JCTLM), and was used to certify SRM 967a.
Start Date:October 1, 2003
Lead Organizational Unit:mml
Related Programs and Projects:
SRM 967a Creatinine in Frozen Human Serum
Dodder, N.G., Tai, S.S-C., Sniegoski, L.T., Zhang, N.F., and Welch, M.J., “Certification of Creatinine in a Human Serum Reference Material by GC-MS and LC-MS,” Clin. Chem., 53(9):1694-1699 (2007).